Hello, everyone! This is Perry Tsai, an MD/PhD student at the University of North Carolina at Chapel Hill; and I will be the lead moderator for this discussion on the article outlining the results of IPERGAY trial investigating on-demand pre-exposure prophylaxis. First, a welcome and a thank you to the authors (Drs. Molina, Spire, Tremblay, and Wainberg) and to all of the experts joining our discussion this week. We look forward to hearing your thoughts.
Let's get some initial reactions to the article. Were you surprised by the results, or did they fall within your expectations? Does the conclusion of the authors generate excitement, relief, concern in your field or practice? What have some of your conversations sounded like with colleagues or patients about the results?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this challenge
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.